This is the authors' abstract. We don't add key points for this paper.
Antipsychotic effectiveness in preventing relapse declines around menopausal age in women with schizophrenia or schizoaffective disorder (SSD). It is not known whether systemic menopausal hormone therapy (MHT) can help to prevent psychosis relapse.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Brand et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: